Erlotero 150 mg Tablet
112,19$
18,67$
Erlotero 150 mg Tablet is a targeted anticancer treatment specifically designed for patients battling non-small cell lung cancer (NSCLC) and pancreatic cancer. This medication works by inhibiting the action of epidermal growth factor receptors (EGFR), which are often overactive in these types of cancer, thereby slowing down tumor growth and progression. It is essential for patients to understand that while Erlotero can be effective, it may also lead to side effects such as skin rashes, diarrhea, or liver complications, necessitating regular monitoring by healthcare professionals. Prior to initiating treatment, patients should discuss their medical history, particularly any pre-existing liver conditions or potential drug interactions, with their doctor. Additionally, Erlotero is not recommended for use during pregnancy due to potential risks to the fetus. With careful management and adherence to prescribed regimens, Erlotero 150 mg Tablet can play a crucial role in the comprehensive treatment plan for eligible cancer patients. Always consult with your healthcare provider to determine if this medication aligns with your specific treatment goals and needs.
Quantité
Active Pharmaceutical Ingredient
Uses
• Erlotero 150 mg tablet is primarily used in the treatment of non-small cell lung cancer, a prevalent form of lung cancer. This medication targets specific cancer cells to inhibit their growth and spread. Patients experiencing symptoms such as a persistent cough or chest pain may benefit from this treatment. The effectiveness of Erlotero 150 mg tablet can significantly improve the overall management of this condition.
• In the context of pancreatic cancer, Erlotero 150 mg tablet is often administered alongside gemcitabine. This combination therapy aims to enhance the efficacy of treatment for patients diagnosed with pancreatic cancer. Symptoms like abdominal pain and jaundice may indicate the need for such a therapeutic approach. By using Erlotero 150 mg tablet, healthcare providers can help manage these symptoms more effectively.
• Erlotero 150 mg tablet serves as an important option for patients with advanced or metastatic cancers. It works by interfering with the growth signals in cancer cells, which can be particularly beneficial in aggressive disease forms. Patients undergoing treatment with Erlotero 150 mg tablet may experience an improvement in their quality of life. This treatment strategy is tailored to address the complexities of cancer progression.
• The use of Erlotero 150 mg tablet extends to cases where targeted therapy is indicated. It is particularly useful for patients whose tumors have specific genetic mutations. By personalizing treatment plans with Erlotero 150 mg tablet, healthcare professionals can offer a more focused approach to cancer care. This targeted action helps in controlling the disease and may lead to better patient outcomes.
Benefits
Erlotero Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Anti-cancer Drug Erlotero can help to slow the progression of cancer. Erlotero 150 mg Pack may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Erlotero 150 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Erlotero 150 mg Pack can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Diarrhea
• Vomiting
• Gas
• Heartburn
• Mouth sores
• Constipation
• Headache
• Weight Loss
• Muscle or bone pain
• Anxiety
• Depression
• Hair loss
• Swelling of hands, feet, arms, lower legs or ankles
• Changes in nail and hair appearance
Common Side Effects
• Sudden chest pain
• Severe stomach pain
• Vision problems
• Heart attack
• Stroke
• Kidney or liver problems
• Rash
• Cough
• Peeling, blistering, cracked or dry skin
• Itching
• Tenderness
• Burning of the skin
• Fever
• Ingrown eyelash
• Pain in the neck, upper back or arms
• Difficult or slow speech
• Dizziness
• Weakness
• Dry mouth
• Dark urine
• Yellow or pale skin
How To Use
Take this medicine on an empty stomach, one hour before food or two hours after food. It is best to take exactly as prescribed by your doctor. Do not take more or less than directed. If you have trouble swallowing the Erlotero 150 mg, you may crush the tablets and mix the powder with a small amount of water. Drink the mixture immediately. You should take the Erlotero 150 mg Tablet at the same time each day to help you remember to take it. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not stop taking the Erlotinib Tablet 150 mg without first consulting your doctor.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Erlotero 150 mg Pack. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Erlotero 150 mg Pack is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Erlotero 150 mg Tablet is recommended. The use of Erlotero 150 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Erlotero Tablet. Erlotero 150 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Erlotero 150 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Erlotero Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Erlotero 150 mg Tablet is recommended. The use of Erlotinib Tablet 150 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Erlotinib Tablet 150 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erlotero 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Anti-cancer Drug Erlotero is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Erlotero 150 mg Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved